moatshark My

All holdings

Scotts Miracle-Gro

SMG

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
0
In their latest 13F (Q3 2026)
See who
Value held
$0k
Combined value at quarter end
Last quarter
0 bought
2 sold or trimmed
Price at Q1 ’26 end
$60.81
+4.2% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

-12.8%Q2 ’24
+33.3%Q3 ’24
-23.5%Q4 ’24
-17.3%Q1 ’25
+20.2%Q2 ’25
-13.7%Q3 ’25
+2.5%Q4 ’25
+4.2%Q1 ’26
Q2 ’24: -12.8%; Q3 ’24: +33.3%; Q4 ’24: -23.5%; Q1 ’25: -17.3%; Q2 ’25: +20.2%; Q3 ’25: -13.7%; Q4 ’25: +2.5%; Q1 ’26: +4.2%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

1Q4 ’23
1Q1 ’24
1Q2 ’24
1Q3 ’24
1Q4 ’24
1Q1 ’25
1Q2 ’25
1Q3 ’25
1Q4 ’25
2Q1 ’26
0Q2 ’26
0Q3 ’26
Q4 ’23: 1; Q1 ’24: 1; Q2 ’24: 1; Q3 ’24: 1; Q4 ’24: 1; Q1 ’25: 1; Q2 ’25: 1; Q3 ’25: 1; Q4 ’25: 1; Q1 ’26: 2; Q2 ’26: 0; Q3 ’26: 0

Counts the managers on this site whose 13F for that quarter includes Scotts Miracle-Gro.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

No manager on this site held it in their latest 13F.

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works
From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.
Insider purchases and sales of Scotts Miracle-Gro
Bought or soldFiling
10 Aug 2026Kingdon Mark DDirector▼ Sold831$61.65$51kForm 4
3 Aug 2026Hagedorn Partnership, L.P.Director▼ Sold28,793$67.42$1.9mForm 4
3 Aug 2026Hagedorn Partnership, L.P.Director▼ Sold1,207$68.16$82kForm 4
30 Jul 2026Johnson Stephen LDirector▼ Sold1,170.96$68.32$80kForm 4

About the company

Sector
Materials · Agricultural Chemicals
Incorporated in
Ohio
Financial year ends
30 September
Shares outstanding
58m at 31 Jul 2026
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

$2.8bnSep ’13
$3.0bnSep ’15
$2.6bnSep ’17
$3.2bnSep ’19
$4.9bnSep ’21
$3.6bnSep ’23
$3.4bnSep ’25
Sep ’13: $2.8bn; Sep ’14: $2.8bn; Sep ’15: $3.0bn; Sep ’16: $2.5bn; Sep ’17: $2.6bn; Sep ’18: $2.7bn; Sep ’19: $3.2bn; Sep ’20: $4.1bn; Sep ’21: $4.9bn; Sep ’22: $3.9bn; Sep ’23: $3.6bn; Sep ’24: $3.6bn; Sep ’25: $3.4bn
Scotts Miracle-Gro revenue and net income by year
YearRevenueNet income
Year to Sep 2025$3.4bn$145m
Year to Sep 2024$3.6bn−$34.9m
Year to Sep 2023$3.6bn−$380m
Year to Sep 2022$3.9bn−$438m
Year to Sep 2021$4.9bn$513m
Year to Sep 2020$4.1bn$387m
Year to Sep 2019$3.2bn$461m
Year to Sep 2018$2.7bn$63.7m
Year to Sep 2017$2.6bn$218m
Year to Sep 2016$2.5bn$315m
Year to Sep 2015$3.0bn$160m
Year to Sep 2014$2.8bn$167m
Year to Sep 2013$2.8bn$161m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.

Sold out last quarter